A Phase 3b Study to Assess the Safety of Novartis Meningococcal B Recombinant Vaccine When Administered in Healthy At-risk Adults

Clinical trial NCT01478347 · COMPLETED

Trial details

NCT number: NCT01478347
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Meningococcal Disease Meningococcal Meningitis

Start date: 2013-05-01
Primary completion: 2014-03-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.